back Back to news
Health Economy Country 2025-11-24T16:21:15+00:00

Novo Nordisk Shares Plummet After Alzheimer's Drug Trial Failure

Novo Nordisk shares dropped 11% following the failure of a major clinical trial for an Alzheimer's drug, causing significant concern in the financial markets.

Novo Nordisk Shares Plummet After Alzheimer's Drug Trial Failure

Shares of Danish pharmaceutical company Novo Nordisk fell approximately 11% on Monday after the company announced the failure of a key endpoint in a clinical trial for a much-anticipated Alzheimer's disease treatment.

This news dealt a significant blow to the company and raised concerns among investors about the future of its promising research in neurodegenerative diseases. The company's stock continues to face pressure following the announcement of the trial's failure.

Latest news

See all news
Danish Study Links Children's Screen Time to Heart Disease Risk
2025-11-10T04:19:12+00:00

Danish Study Links Children's Screen Time to Heart Disease Risk

A new Danish study shows that each additional hour of screen time increases the risk of heart and metabolic problems in children and teens. Experts recommend limiting gadget use and monitoring sleep quality.
Health Events Country
Novo Nordisk makes offer to acquire Mitsera
2025-10-30T16:09:12+00:00

Novo Nordisk makes offer to acquire Mitsera

The Danish pharmaceutical company Novo Nordisk has made an offer to acquire Mitsera, which could be a key step in its expansion strategy and open new opportunities for patients.
Economy Health Country
Study Reveals Gender Differences in Health Risks
2025-05-06T16:30:44+00:00

Study Reveals Gender Differences in Health Risks

A new study highlights that men have a higher risk of death from hypertension, diabetes, and AIDS compared to women, despite similar infection rates. It emphasizes the need for targeted healthcare programs.
Health Country